These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8338890)

  • 21. Complement and complement regulatory proteins in human tears.
    Willcox MD; Morris CA; Thakur A; Sack RA; Wickson J; Boey W
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):1-8. PubMed ID: 9008624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement. Historical perspectives and some current issues.
    Mayer MM
    Complement; 1984; 1(1):2-26. PubMed ID: 6100484
    [No Abstract]   [Full Text] [Related]  

  • 23. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.
    Hu VW; Esser AF; Podack ER; Wisnieski BJ
    J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
    Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1978 Dec; 148(6):1722-7. PubMed ID: 722244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of complement deficiencies.
    Pettigrew HD; Teuber SS; Gershwin ME
    Ann N Y Acad Sci; 2009 Sep; 1173():108-23. PubMed ID: 19758139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
    Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
    [No Abstract]   [Full Text] [Related]  

  • 27. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Threshold mechanism of the control of cascade proteolysis].
    Shcherbak IG
    Bioorg Khim; 1998 May; 24(5):364-9. PubMed ID: 9661790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reactivity of the complement system.
    Rother K; Rother U
    Prog Allergy; 1986; 39():8-23. PubMed ID: 3562476
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of complement messenger RNAs and proteins by human oligodendroglial cells.
    Hosokawa M; Klegeris A; Maguire J; McGeer PL
    Glia; 2003 Jun; 42(4):417-23. PubMed ID: 12730962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interactions between complement system and bacterial walls].
    Colomb MG; Bensa JC; Chesne S; Aubert B
    Bull Eur Physiopathol Respir; 1983; 19(2):131-6. PubMed ID: 6871492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological studies of human placentae: complement components in immature and mature chorionic villi.
    Faulk WP; Jarret R; Keane M; Johnson PM; Boackle RJ
    Clin Exp Immunol; 1980 May; 40(2):299-305. PubMed ID: 7002386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA.
    Seelen MA; Roos A; Wieslander J; Mollnes TE; Sjöholm AG; Wurzner R; Loos M; Tedesco F; Sim RB; Garred P; Alexopoulos E; Turner MW; Daha MR
    J Immunol Methods; 2005 Jan; 296(1-2):187-98. PubMed ID: 15680163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritoneal mesothelial cells produce complement factors and express CD59 that inhibits C5b-9-mediated cell lysis.
    Barbano G; Cappa F; Prigione I; Tedesco F; Pausa M; Gugliemino R; Pistoia V; Gusmano R; Perfumo F
    Adv Perit Dial; 1999; 15():253-7. PubMed ID: 10682113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteriolytic activity of the alternative pathway of complement differs kinetically from the classical pathway.
    Kilpi MK; Atosuo JT; Lilius EM
    Dev Comp Immunol; 2009 Oct; 33(10):1102-10. PubMed ID: 19527746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis.
    Ben Nasr A; Klimpel GR
    J Leukoc Biol; 2008 Jul; 84(1):77-85. PubMed ID: 18430786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.